ArticleCancer science2026

Genetic Engineering of Tumor-Infiltrating Lymphocytes (TIL) via a T-Editor Platform to Enhance Anti-Tumor Activity.

Fenge Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.